[go: up one dir, main page]

NO20003283L - Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt - Google Patents

Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt

Info

Publication number
NO20003283L
NO20003283L NO20003283A NO20003283A NO20003283L NO 20003283 L NO20003283 L NO 20003283L NO 20003283 A NO20003283 A NO 20003283A NO 20003283 A NO20003283 A NO 20003283A NO 20003283 L NO20003283 L NO 20003283L
Authority
NO
Norway
Prior art keywords
sodium ion
prophylactic
therapeutic agents
absorption inhibitors
diseases resulting
Prior art date
Application number
NO20003283A
Other languages
English (en)
Other versions
NO20003283D0 (no
Inventor
Takaya Sato
Tutomu Uehara
Ippei Yamaoka
Kozo Asagi
Masaru Kobayashi
Hideaki Kohri
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO20003283D0 publication Critical patent/NO20003283D0/no
Publication of NO20003283L publication Critical patent/NO20003283L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Natriumion-absorpsjonsinhibitor, natriumion-utskillingsaksel- erator og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt som inneholder salter av X-karrageenan med metaller unntatt natrium som den aktive bestanddel kan bevirke at overskytende koksalt som er inntatt kan skilles ut av kroppen på en pågående og sikker måte, og de er særlig utmerkede med hensyn til å utskille natriumioner i feces.
NO20003283A 1997-12-25 2000-06-22 Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt NO20003283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35760997 1997-12-25
PCT/JP1998/005873 WO1999033478A1 (fr) 1997-12-25 1998-12-24 Inhibiteurs d'absorption d'ions sodium, agents pour accelerer l'excretion d'ions sodium, et agents pour prevenir et traiter les maladies provoquees par une absorption excessive de chlorure de sodium

Publications (2)

Publication Number Publication Date
NO20003283D0 NO20003283D0 (no) 2000-06-22
NO20003283L true NO20003283L (no) 2000-08-25

Family

ID=18455004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003283A NO20003283L (no) 1997-12-25 2000-06-22 Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt

Country Status (7)

Country Link
US (1) US6369043B1 (no)
EP (1) EP1043022B1 (no)
AT (1) ATE366580T1 (no)
CA (1) CA2316387A1 (no)
DE (1) DE69838076T2 (no)
NO (1) NO20003283L (no)
WO (1) WO1999033478A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780873B2 (en) * 2000-01-14 2005-04-21 Otsuka Pharmaceutical Factory, Inc. Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same
EP2633851B1 (en) * 2006-09-26 2016-08-24 Basf Beauty Care Solutions LLC Sarcodiotheca extracts and biofermentations for use in cosmetics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353890A (en) * 1979-10-24 1982-10-12 Colgate-Palmolive Company Stabilization of carrageenan-containing toothpaste
JP3194267B2 (ja) 1990-01-09 2001-07-30 株式会社アドバンス 排塩促進組成物の製造方法
US5344844A (en) * 1990-01-09 1994-09-06 Kabushiki Kaisya Advance Salt excretion promoting composition
JP3206045B2 (ja) 1991-10-11 2001-09-04 スズキ株式会社 自動変速機の操作装置
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤

Also Published As

Publication number Publication date
CA2316387A1 (en) 1999-07-08
WO1999033478A1 (fr) 1999-07-08
DE69838076D1 (de) 2007-08-23
ATE366580T1 (de) 2007-08-15
EP1043022A4 (en) 2003-07-30
EP1043022B1 (en) 2007-07-11
DE69838076T2 (de) 2008-03-20
US6369043B1 (en) 2002-04-09
EP1043022A1 (en) 2000-10-11
NO20003283D0 (no) 2000-06-22

Similar Documents

Publication Publication Date Title
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
NZ503340A (en) Treatment for hairy hoof warts (papiliomatous digital dermatitis, or PDD)
UY26269A1 (es) Formulación de sal común y moxifloxacina
EP1539234A4 (en) METHOD FOR PREVENTING OR TREATING CELL MALIGNITY BY ADMINISTERING CD2 ANTAGONISTS
MX9707569A (es) Un metodo para el tratamiento de la degeneracion macular.
WO2004029031A3 (en) Therapeutic piperazine compounds
CY1109773T1 (el) Φαρμακα για ασθενειες των αρθρωσεων
NO20034204L (no) Farmasöytiske kombinasjoner til behandling av kreft
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
FI914919A7 (fi) AIDS-potilaiden neurologisten sairauksien hoidossa tehokkaat farmaseuttiset koostumukset, jotka sisältävät vaikuttavana aineena vähintään yhtä yhdistettä, joka on valittu ryhmästä, joka käsittää S-adenosyyli -L-metioniinisuolan, 5-metyylitetrahydrofool
WO2005030753A3 (en) Therapeutic agents useful for treating pain
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
NO20003283D0 (no) Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DE60237111D1 (de) "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür"
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
DK1140103T3 (da) Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
TR200000090T2 (tr) Serotonin'in seçici olarak yeniden yapıya alınma inhibitörleri (SSRI) kullanılarak kalp hastalıklarının tedavisi ve önlenmesi.
PT1156791E (pt) Bupropiona para tratar doencas virais
BR0108133A (pt) Agente de tratamento para a osteoartrite
HRP20040303B1 (hr) Uporaba specifične doze fondaparinuks natrija za liječenje aks
BR9911150A (pt) Método de tratamento
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application